REGISTER
Rethinking Global Type 2 Diabetes Prevention
MedJ speaks with Dr. Mohammed K. Ali of Emory University on global type 2 diabetes trends, prevention strategies, evidence-to-policy translation, and cost-effective diabetes management in resource-limited settings.

Mohammed K. Ali, MD, Emory University, USA (Co-Director, Emory Global Diabetes Research Center)


In this ADA 2026 expert interview, MedJ speaks with Dr. Mohammed K. Ali about key issues in diabetes epidemiology, global health, and prevention policy. Drawing on his long-standing work in global diabetes research, Dr. Ali discusses the most underappreciated shifts in the global type 2 diabetes landscape over the past decade and how clinicians should rethink prevention strategies accordingly. He also shares insights on translating effective clinical prevention interventions into public policy, including the key levers that help move research evidence into policy adoption and the lessons learned when implementation falls short. In addition, Dr. Ali reflects on cost-effective but often overlooked interventions for diabetes management in low- and middle-income settings.

0
0
Loading